Cold plasma therapy as adjuvant to radiotherapy for breast cancer treatment

The goal of this research is to improve breast cancer local control and reduce treatment side effects by demonstrating that a new cold plasma technology, which generates locally specific reactive oxygen species, has an additive positive treatment impact when combined with conventional radiotherapy. This project has the potential to enable a Canadian technology, to become an adjuvant for radiotherapy. This project will perform the preclinical trials required to provide the fist evidences that this technology has the potential to become a clinically relevant tool when used in conjunction with radiotherapy.

Faculty Supervisor:

Sylvain Coulombe

Student:

Jean-Sébastien Boisvert

Partner:

Instadesign Dev

Discipline:

Engineering - chemical / biological

Sector:

Life sciences

University:

Université de Montréal